References
- Wolff JM, Zitelli JA, Rabin BS et al, Intralesional interferon in the treatment of early mycosis fungoides. J Am Acad Dermatol (1985) 13: 604–12.
- Richwald GA, Imiquimod. Drugs of Today (1999) 35(7): 497–511.
- Edwards L, Ferenczy A, Eron L et al, Self-administered topical 5% imiquimod cream for external anogenital warts. Arch Dermatol (1998) 134: 25–30.
- Hengge UR, Esser S, Schultewolter T et al, Self-administered topical 5% imiquimod for the treatment of common warts and molluscum contagiosum. Br J Dermatol (2000) 143: 1026–31.
- Mackenzie-Wood A, de Launey J, Kossard S et al, Safety and efficacy of imiquimod 5% cream for the treatment of Bowen’s disease. J Invest Dermatol (1998) 110: 684.
- Beutner KR, Geisse JK, Helman D et al, Therapeutic response of basal cell carcinoma to the immune response modifier imiquimod 5% cream. J Am Acad Dermatol (1999) 41: 1002–7.
- Petrow W, Gerdsen R, Uerlich M et al, Successful topical immunotherapy of bowenoid papulosis with imiquimod. Br J Dermatol (2001) 145: 1022–3.
- Suchin KR, Junkins-Hopkins JM, Rook AH, Treatment of stage 1A cutaneous T-cell lymphoma with topical application of the immune response modifier imiquimod. Arch Dermatol (2002) 138: 1137–9.